Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Blue Sky Specialty Pharmacy
AddedFeb 17, 2024
UpdatedJun 18, 2026
Blue Sky Specialty Pharmacy

Blue Sky Specialty Pharmacy

Series A

Blue Sky Specialty Pharmacy: Streamlining prescriptions with tech for transparent medication access.

HQ
Mount Pleasant, SC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to streamline the prescription process, Blue Sky Specialty Pharmacy leverages advanced technology to provide transparent and efficient access to necessary medications. The company focuses on meeting the needs of patients, physicians, payers, and pharmaceutical manufacturers by offering specialized pharmacy services. Their core vision is to place patients at the forefront, ensuring they receive the medications they need promptly and with ease.

Blue Sky Specialty Pharmacy has garnered attention for its innovative approach to simplifying the complex world of prescriptions. Notable affiliated individuals include experienced healthcare professionals and tech experts who drive the company's mission forward. Key achievements include the successful implementation of a technology-driven platform that enhances prescription transparency and efficiency. The overall impact of Blue Sky Specialty Pharmacy is reflected in its ability to improve patient outcomes and streamline the healthcare process for all stakeholders involved.

Blue Sky Specialty Pharmacy - Quick Facts

When was Blue Sky Specialty Pharmacy founded?

Blue Sky Specialty Pharmacy was founded in 2015.

Where is Blue Sky Specialty Pharmacy's headquarters located?

Blue Sky Specialty Pharmacy's headquarters is located in Mount Pleasant, SC, US.

When was Blue Sky Specialty Pharmacy's last funding round?

Blue Sky Specialty Pharmacy's most recent funding round was for $10M (USD) in September 2022.

How much has Blue Sky Specialty Pharmacy raised to-date?

As of Sep 8, 2022, Blue Sky Specialty Pharmacy has raised a total of $10M (USD).

How many employees does Blue Sky Specialty Pharmacy have?

Blue Sky Specialty Pharmacy has 75 employees as of Feb 4, 2024.

Blue Sky Specialty Pharmacy - Classification

Ownership
  • Private
Technology
  • Technology
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
  • Enterprise
Main Product
  • Specialty Pharmacy
Tags
  • Healthtech
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 440000Retail Trade
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores